Literature DB >> 17097661

Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells.

Rosaria Piga1, Yuji Naito, Satoshi Kokura, Osamu Handa, Toshikazu Yoshikawa.   

Abstract

Acute, short-term hyperglycemia is becoming recognized as an important risk factor for several diseases. In the present study, using human aortic endothelial cells (HAECs), we investigated whether short-term high glucose exposure, either on the scale of hours, could enhance the monocyte adhesion and migration to the subendothelium via increasing expression of adhesion molecules and release of chemotactic factors. HAECs stimulated with 25mM d(+)glucose (HG) for not more than 12h, exhibited rapid up-regulation of vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP-1) mRNA and protein. Although intercellular adhesion molecule-1 (ICAM-1) is considered as a marker of the activation of the atherogenic process, early up-regulation was not observed, and VCAM-1 and MCP-1 protein enhance was sufficient to increase the adhesiveness of human monocytes U-937 to HAECs and their transmigration into the subendothelial space after 4h HG stimulation; both effects were prevented by interfering with monoclonal antibodies against VCAM-1, CD11b, and MCP-1. An increased intracellular oxidative stress, a translocation of NF-kappaB to the nucleus and a prevention of adhesion and transmigration of U-937 by interfering with NF-kappaB inhibitors was also observed after a short HG treatment. Taken together, these results suggest that either acute hyperglycemic spikes could exert an influence on the onset of diabetic complications and on the development of the atherogenic profile on diabetic and non-diabetic subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097661     DOI: 10.1016/j.atherosclerosis.2006.09.016

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  59 in total

1.  Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.

Authors:  Theodore Mazzone
Journal:  Circulation       Date:  2010-11-23       Impact factor: 29.690

2.  The effect of short-term, high glucose concentration on endothelial cells and leukocytes in a 3D in vitro human vascular tissue model.

Authors:  H Gappa-Fahlenkamp; A S Shukla
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-01-28       Impact factor: 2.416

Review 3.  The pathologic continuum of diabetic vascular disease.

Authors:  Gabriela Orasanu; Jorge Plutzky
Journal:  J Am Coll Cardiol       Date:  2009-02-03       Impact factor: 24.094

Review 4.  Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.

Authors:  Corey E Tabit; William B Chung; Naomi M Hamburg; Joseph A Vita
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

5.  Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells.

Authors:  Luciano Pirola; Aneta Balcerczyk; Richard W Tothill; Izhak Haviv; Antony Kaspi; Sebastian Lunke; Mark Ziemann; Tom Karagiannis; Stephen Tonna; Adam Kowalczyk; Bryan Beresford-Smith; Geoff Macintyre; Ma Kelong; Zhang Hongyu; Jingde Zhu; Assam El-Osta
Journal:  Genome Res       Date:  2011-09-02       Impact factor: 9.043

6.  C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia.

Authors:  Jaime Haidet; Vincenza Cifarelli; Massimo Trucco; Patrizia Luppi
Journal:  Inflamm Res       Date:  2011-09-27       Impact factor: 4.575

Review 7.  Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants.

Authors:  Joan M Cook-Mills; Michelle E Marchese; Hiam Abdala-Valencia
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

Review 8.  Implicating endothelial cell senescence to dysfunction in the ageing and diseased brain.

Authors:  Sara I Graves; Darren J Baker
Journal:  Basic Clin Pharmacol Toxicol       Date:  2020-03-23       Impact factor: 4.080

Review 9.  Epigenetic Changes in Diabetes and Cardiovascular Risk.

Authors:  Samuel T Keating; Jorge Plutzky; Assam El-Osta
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

10.  Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) mice.

Authors:  E Di Marco; S P Gray; P Chew; C Koulis; A Ziegler; C Szyndralewiez; R M Touyz; H H H W Schmidt; M E Cooper; R Slattery; K A Jandeleit-Dahm
Journal:  Diabetologia       Date:  2013-11-30       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.